The Company hereby submit drafts intimation letter sent to holders of Physical shares of the company for updating PAN, KYC, Nomination and other details in accordance with applicable SEBI ....
BIOFILCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Biofil Chemicals & Pharmaceuticals Ltd has filed an intimation under SEBI Listing Regulations (Regulation 30) informing shareholders about a mandatory requirement to update their PAN, KYC details, contact information (postal address with PIN and mobile number), bank account details, and specimen signature with the company's Registrar and Share Transfer Agent (RTA), Ankit Consultancy Private Limited. This is in compliance with SEBI's Master Circular dated 6th February 2026. Physical shareholders who fail to update these details will only be eligible to lodge grievances or avail service requests from the RTA after furnishing the required information. Additionally, any payments including dividends, interest, or redemption payments will be made only through electronic mode from 1st April 2024. The company is sending draft intimation letters to affected physical share holders along with relevant forms (ISR-1, ISR-2, ISR-3, SH-13, SH-14, etc.) and links to the RTA's website for submission.
This is a standard regulatory compliance filing with no direct impact on the company's financial performance or stock price. Physical shareholders who do not update their details risk delayed or blocked dividend payments and restricted access to RTA services.